Endothelial protection in lung grafts through heparanase inhibition during ex vivo lung perfusion in rats

被引:1
|
作者
Noda, Kentaro [1 ]
Philips, Brian J. [1 ]
Atale, Neha [1 ]
Sanchez, Pablo G. [1 ,2 ]
机构
[1] Univ Pittsburgh, Dept Cardiothorac Surg, Div Lung Transplant & Lung Failure, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Cardiothorac Surg, Div Lung Transplant & Lung Failure, UPMC Presbyterian C 900 200 Lothrop St, Pittsburgh, PA 15213 USA
来源
关键词
Lung transplantation; Ex vivo lung perfusion; endothelial glycocalyx; endothelial protection; heparanase; INFLAMMATION; DYSFUNCTION; PATHWAY; ACID;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: We hypothesized that enhancing glycocalyx preservation would reduce endothelial damage in lung grafts during ex-vivo lung perfusion (EVLP) leading to better transplant outcomes. In this study, we characterized the effects of inhibiting heparanase (HPSE), an enzyme responsible for glycocalyx shedding, on lung quality during EVLP. METHODS: Human clinical EVLP perfusate from lung graft patients was utilized to identify a potential association between glycocalyx integrity in grafted lung tissue and clinical data. In addition, we performed pre-clinical studies in which rat lungs underwent normothermic EVLP for 4 hours with/without HPSE inhibitors, heparin (1,000-U/h) or heparastatin (SF4; 1-mM), added to the perfusate. After 4hours EVLP, left lungs were transplanted into syngeneic rats then evaluated for graft quality 2-hours after reperfusion. RESULTS: Clinically, increased degradation of syndecan-1 was identified in dysfunctional grafts during EVLP. Levels of heparan sulfate in perfusate after EVLP were associated with incidence of graft dysfunction after transplantation. In the pre-clinical rat study, SF4 effectively inhibited HPSE activity, and significantly attenuated dissociated glycocalyx levels, endothelial dysfunction, edema, and inflammation in lungs during EVLP compared to both controls and heparin groups. High-doses of heparin demonstrated markedly increased perfusate syndecan-1 concentrations and deteriorated lung quality during EVLP compared with controls. Post-transplant graft function and inflammation were significantly improved in SF4-treated group compared to those in both control and heparin-treated groups. CONCLUSIONS: This study demonstrated that HPSE activity inhibition by SF4 can improve graft preservation during EVLP by protecting the glycocalyx and endothelial function, leading to better lung function following transplantation. (c) 2023 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Impact of Heparin on Endothelial Glycocalyx in Lung Grafts during Ex Vivo Lung Perfusion
    Noda, K.
    Philips, B. J.
    Ren, X.
    Sanchez, P. G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S344 - S345
  • [2] Hydrogen Inhalation during Ex Vivo Lung Perfusion Ameliorates the Quality of Lung Grafts in Rats
    Noda, K.
    Shigemura, N.
    Tanaka, Y.
    Bermudez, C. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S66 - S67
  • [3] Hydrogen Preconditioning During Ex Vivo Lung Perfusion Improves the Quality of Lung Grafts in Rats
    Noda, Kentaro
    Shigemura, Norihisa
    Tanaka, Yugo
    Bhama, Jay
    D'Cunha, Jonathan
    Kobayashi, Hirosuke
    Luketich, James D.
    Bermudez, Christian A.
    TRANSPLANTATION, 2014, 98 (05) : 499 - 506
  • [4] Preconditioning Lung Grafts with Inhaled Hydrogen during Ex Vivo Lung Perfusion Improves Posttransplant Lung Grafts Function
    Noda, K.
    Shigemura, N.
    Tanaka, Y.
    Saito, Y.
    Bhama, J. K.
    D'Cunha, J.
    Bermudez, C. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S27 - S27
  • [5] Dual Ex Vivo Lung Perfusion Techniques Ameliorate Airway Hypoxia in Lung Grafts in Rats
    Tanaka, Y.
    Shigemura, N.
    Noda, K.
    Saito, Y.
    Maniwa, Y.
    Bhama, J. K.
    D'Cunha, J.
    Bermudez, C. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S27 - S27
  • [6] Pyroptosis of Passenger Leukocytes Negatively Impacts the Quality of Lung Grafts During Ex Vivo Lung Perfusion
    Noda, K.
    Tane, S.
    Hayanga, A. J.
    D'Cunha, J.
    Luketich, J. D.
    Shigemura, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S373 - S373
  • [7] Cyclosporine Preconditioning During Ex Vivo Lung Perfusion Improves the Quality of Post Transplant Lung Grafts
    Noda, K.
    Haam, S.
    Tane, S.
    D'Cunha, J.
    Luketich, J. D.
    Shigemura, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S222 - S222
  • [8] Cyclosporin A Administration During Ex Vivo Lung Perfusion Preserves Lung Grafts in Rat Transplant Model
    Haam, Seokjin
    Noda, Kentaro
    Philips, Brian J.
    Harano, Takashi
    Sanchez, Pablo G.
    Shigemura, Norihisa
    TRANSPLANTATION, 2020, 104 (09) : E252 - E259
  • [9] Repair of Endothelial Glycocalyx Improves Lung Function During Human Ex Vivo Lung Perfusion
    Hogan, S.
    Givens, C.
    Buie, L.
    Wade, L.
    Popa, S.
    Wannberg, B.
    Benjamin, J.
    Petersen, T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S299 - S299
  • [10] Heparanase inhibition preserves the endothelial glycocalyx in lung grafts and improves lung preservation and transplant outcomes
    Noda, Kentaro
    Philips, Brian J.
    Snyder, Mark E.
    Phillippi, Julie A.
    Sullivan, Mara
    Stolz, Donna B.
    Ren, Xi
    Luketich, James D.
    Sanchez, Pablo G.
    SCIENTIFIC REPORTS, 2021, 11 (01)